AI: DeepSeek (deepseek-chat)

Q: {
  "clinicalNote": "<p>### Summary: <br>- Age: 54 years <br>- BMI: 36.4 (obesity) <br>- G4P4, history of gestational diabetes in all pregnancies <br>- Presenting complaint: Poorly controlled T2DM (HbA1c 8.2%), postprandial hyperglycemia (180–220 mg/dL), occasional fatigue and blurred vision <br>- Comorbidities: Hypertension, hyperlipidemia <br>- Current medications: Metformin, lisinopril, atorvastatin, aspirin <br>- Lifestyle: Sedentary, carbohydrate-heavy diet, minimal exercise <br><br>### Detailed Issues and Advice: <br>- **Glycemic Control**: Patient reports persistent postprandial hyperglycemia despite metformin adherence. <br>- Doctor advises considering SGLT2 inhibitor (e.g., empagliflozin) or GLP-1 RA (e.g., semaglutide) for additional glycemic control and weight management. <br>- Basal insulin is a potential option if oral agents fail, with education to address patient’s concerns. <br>- **Lifestyle**: Patient admits to poor diet and minimal exercise. <br>- Doctor recommends referral to diabetes educator and dietitian for carbohydrate management and structured exercise (150 min/week). <br>- **Monitoring**: Continue home glucose logs and ensure annual diabetic eye/foot exams. <br><br>### Plan: <br>1. **Glycemic Control**: <br>- Consider adding SGLT2 inhibitor (e.g., empagliflozin) or GLP-1 RA (e.g., semaglutide). <br>- If oral agents fail, discuss basal insulin initiation with patient education. <br>2. **Lifestyle Modifications**: <br>- Refer to diabetes educator and dietitian for carbohydrate management. <br>- Encourage structured exercise (150 min/week). <br>3. **Monitoring**: <br>- Repeat HbA1c, renal function, and fasting lipid panel. <br>- Continue home glucose monitoring (fasting + postprandial). <br>- Schedule annual diabetic eye and foot exams. <br>4. **Follow-Up**: <br>- Re-evaluate in 4 weeks for medication adjustment and adherence assessment.</p>",
  "guidelines": [
    "Uptodate - 2025 - Preexisting and gestational diabetes - Intrapartum and postpartum glucose management",
    "BJOG - 2018 - Denison - Care of Women with Obesity in Pregnancy"
  ],
  "prompt": "You are provided with the text of a clinical note from a patient encounter and a set of clinical guidelines. Your task is to:\n\n1. Cross-check the clinical note against each provided guideline.\n2. Identify areas in the clinical note that do not fully adhere to the guideline recommendations.\n3. Note any parts of the note that could be improved based on the guidelines.\n4. Return ONLY the HTML-formatted clinical note with the suggested changes.\n\nThe clinical note should be output as valid HTML.\nAny text in the clinical note that has been adjusted or needs adjustment (in light of the guidelines) should be wrapped in <i></i> tags (to display in italics).\nNext to each suggested change, provide the guideline reference in parentheses (e.g., the guideline's name or identifier).\n\nDO NOT include any explanatory text, introduction, or conclusion in your response.\nDO NOT include the complete text of each guideline in your response.\nDO NOT use markdown or code formatting in your response.\nONLY return the modified clinical note in HTML format, with no additional commentary.\n\nHere is the note text: <p>### Summary: <br>- Age: 54 years <br>- BMI: 36.4 (obesity) <br>- G4P4, history of gestational diabetes in all pregnancies <br>- Presenting complaint: Poorly controlled T2DM (HbA1c 8.2%), postprandial hyperglycemia (180–220 mg/dL), occasional fatigue and blurred vision <br>- Comorbidities: Hypertension, hyperlipidemia <br>- Current medications: Metformin, lisinopril, atorvastatin, aspirin <br>- Lifestyle: Sedentary, carbohydrate-heavy diet, minimal exercise <br><br>### Detailed Issues and Advice: <br>- **Glycemic Control**: Patient reports persistent postprandial hyperglycemia despite metformin adherence. <br>- Doctor advises considering SGLT2 inhibitor (e.g., empagliflozin) or GLP-1 RA (e.g., semaglutide) for additional glycemic control and weight management. <br>- Basal insulin is a potential option if oral agents fail, with education to address patient’s concerns. <br>- **Lifestyle**: Patient admits to poor diet and minimal exercise. <br>- Doctor recommends referral to diabetes educator and dietitian for carbohydrate management and structured exercise (150 min/week). <br>- **Monitoring**: Continue home glucose logs and ensure annual diabetic eye/foot exams. <br><br>### Plan: <br>1. **Glycemic Control**: <br>- Consider adding SGLT2 inhibitor (e.g., empagliflozin) or GLP-1 RA (e.g., semaglutide). <br>- If oral agents fail, discuss basal insulin initiation with patient education. <br>2. **Lifestyle Modifications**: <br>- Refer to diabetes educator and dietitian for carbohydrate management. <br>- Encourage structured exercise (150 min/week). <br>3. **Monitoring**: <br>- Repeat HbA1c, renal function, and fasting lipid panel. <br>- Continue home glucose monitoring (fasting + postprandial). <br>- Schedule annual diabetic eye and foot exams. <br>4. **Follow-Up**: <br>- Re-evaluate in 4 weeks for medication adjustment and adherence assessment.</p>\nHere is each guideline with the title followed by the guideline:\nUptodate - 2025 - Preexisting and gestational diabetes - Intrapartum and postpartum glucose management\nBJOG - 2018 - Denison - Care of Women with Obesity in Pregnancy"
}

A: <p>### Summary: <br>- Age: 54 years <br>- BMI: 36.4 (obesity) <br>- G4P4, history of gestational diabetes in all pregnancies <br>- Presenting complaint: Poorly controlled T2DM (HbA1c 8.2%), postprandial hyperglycemia (180–220 mg/dL), occasional fatigue and blurred vision <br>- Comorbidities: Hypertension, hyperlipidemia <br>- Current medications: Metformin, lisinopril, atorvastatin, aspirin <br>- Lifestyle: Sedentary, carbohydrate-heavy diet, minimal exercise <br><br>### Detailed Issues and Advice: <br>- **Glycemic Control**: Patient reports persistent postprandial hyperglycemia despite metformin adherence. <br>- Doctor advises considering SGLT2 inhibitor (e.g., empagliflozin) or GLP-1 RA (e.g., semaglutide) for additional glycemic control and weight management. <i>(Uptodate - 2025 - Preexisting and gestational diabetes - Intrapartum and postpartum glucose management)</i> <br>- Basal insulin is a potential option if oral agents fail, with education to address patient’s concerns. <br>- **Lifestyle**: Patient admits to poor diet and minimal exercise. <br>- Doctor recommends referral to diabetes educator and dietitian for carbohydrate management and structured exercise (150 min/week). <i>(BJOG - 2018 - Denison - Care of Women with Obesity in Pregnancy)</i> <br>- **Monitoring**: Continue home glucose logs and ensure annual diabetic eye/foot exams. <br><br>### Plan: <br>1. **Glycemic Control**: <br>- Consider adding SGLT2 inhibitor (e.g., empagliflozin) or GLP-1 RA (e.g., semaglutide). <i>(Uptodate - 2025 - Preexisting and gestational diabetes - Intrapartum and postpartum glucose management)</i> <br>- If oral agents fail, discuss basal insulin initiation with patient education. <br>2. **Lifestyle Modifications**: <br>- Refer to diabetes educator and dietitian for carbohydrate management. <i>(BJOG - 2018 - Denison - Care of Women with Obesity in Pregnancy)</i> <br>- Encourage structured exercise (150 min/week). <i>(BJOG - 2018 - Denison - Care of Women with Obesity in Pregnancy)</i> <br>3. **Monitoring**: <br>- Repeat HbA1c, renal function, and fasting lipid panel. <br>- Continue home glucose monitoring (fasting + postprandial). <br>- Schedule annual diabetic eye and foot exams. <br>4. **Follow-Up**: <br>- Re-evaluate in 4 weeks for medication adjustment and adherence assessment.</p>